LENNAR CORP /NEW/ Equity Method Investment, Other than Temporary Impairment
LENNAR CORP /NEW/ (LEN.B) reported Equity Method Investment, Other than Temporary Impairment of $10.70 million for the 9-month period ending 2025-08-31, per its 10-Q filed 2025-10-03.
Financial Statements › Income Statement › Other Income
us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2026-01-28
- LENNAR CORP /NEW/ equity method investment, other than temporary impairment for the quarter ending 2025-08-31 was $0.00.
- LENNAR CORP /NEW/ equity method investment, other than temporary impairment for the quarter ending 2025-05-31 was $3.10M.
- LENNAR CORP /NEW/ equity method investment, other than temporary impairment for the quarter ending 2025-02-28 was $7.60M.
- LENNAR CORP /NEW/ equity method investment, other than temporary impairment for fiscal 2023 was $65.00M.
| Period end | Equity Method Investment, Other than Temporary Impairment 3 month | Equity Method Investment, Other than Temporary Impairment 6 month | Equity Method Investment, Other than Temporary Impairment 9 month | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|---|---|---|
| 2025-08-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-03 | $3.10M derived: sum of 2 quarters · filed 2025-10-03 | $10.70M 10-Q · filed 2025-10-03 | |
| 2025-05-31 | $3.10M 10-Q · filed 2025-07-01 | $10.70M 10-Q · filed 2025-07-01 | ||
| 2025-02-28 | $7.60M 10-Q · filed 2025-04-04 | |||
| 2023-11-30 | $65.00M 10-K · filed 2026-01-28 |